Punekar, S. R., Patel, S. P., Botta, G. P., Ward, J., Kirtane, K., Prasad, D. K., Leal, A., Ulrickson, M., Specht, J. M., Zhen, D. B., Lou, Y., Avila, M., He, K., Dorigo, O., Eng, C., Mitchell, J., Mardiros, A., Welch, J. S., Molina, J. R., Hecht, J. R. (2026). A logic-gated chimeric antigen receptor T-cell (CAR T) therapy with an armored, membrane-tethered IL-12 booster in patients with advanced solid tumors with HLA-A*02 loss of heterozygosity (LOH): EVEREST-2, a phase 1/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2673